Dr. Rose is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1901 1st Ave
New York, NY 10029Phone+1 212-423-7467
Education & Training
- Icahn School of Medicine at Mount SinaiResidency, Dermatology, 2015 - 2018
- Icahn School of Medicine at Mount SinaiFellowship, Dermatopharmacology, 2013 - 2015
- New York Presbyterian Hospital (Cornell Campus)Residency, Anesthesiology, 2010 - 2012
- Albert Einstein College of MedicineClass of 2010
Certifications & Licensure
- NY State Medical License 2013 - 2025
- American Board of Dermatology Dermatology
Clinical Trials
- Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream Start of enrollment: 2013 Jan 01
Publications & Presentations
PubMed
- 221 citationsEfficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatment...Emma Guttman-Yassky, Patrick M. Brunner, Avidan U. Neumann, Saakshi Khattri, Ana B. Pavel
Journal of the American Academy of Dermatology. 2018-05-01 - 119 citationsBaseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumab.Patrick M. Brunner, Ana B. Pavel, Saakshi Khattri, Alexandra Leonard, Kunal Malik
The Journal of Allergy and Clinical Immunology. 2019-01-01 - 12 citationsMagnesium supplementation in the treatment of pseudoxanthoma elasticum: A randomized trial.Sharon Rose, Shelbi Jim On, Wayne Fuchs, Chen Chen, Robert G. Phelps
Journal of the American Academy of Dermatology. 2019-02-28
Research History
- Dermatopharmacology Fellow2013 - 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: